Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: Obstet Gynecol. 2010 Sep;116(3):583–593. doi: 10.1097/AOG.0b013e3181e9e0ab

Fig. 2.

Fig. 2.

Response change for selected outcome measures (mean±standard error of the mean [SEM]) from baseline through week 16 for the four treatment allocations: tampon test (A), intercourse pain (B), algesiometer test (C), cotton swab test-vestibule (D). Week 16 represents open label after completion of randomized phase (baseline to week 12).

Foster. Desipramine and Lidocaine for Vulvodynia. Obstet Gynecol 2010.